Kura Oncology (KURA) Misses Q4 EPS by 66c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.92), $0.66 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $17.34 million versus the consensus estimate of $74.52 million.

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Meta's Zuckerberg Says Ai Agent Tech Progressing Slower Than Expected - Reuters
• Alarum Technologies responds to FBI investigation of subsidiary NetNut